On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications

Tania Ciaglia1, Vincenzo Vestuto1, Alessia Bertamino1

  • 1Dipartimento di Farmacia (DIFARMA), Università degli Studi di Salerno, Fisciano, Italy.

Frontiers in Oncology
|February 27, 2023
PubMed

Insights

Transient receptor potential melastatin (TRPM) channels are crucial for cell signaling and ion balance. Their abnormal expression in cancer suggests TRPM channels are promising therapeutic targets for oncology treatments.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Physiology

Background:

  • Transient receptor potential melastatin (TRPM) channels are vital cellular sensors regulating ion homeostasis and signal transduction.
  • Aberrant TRPM channel expression is linked to various solid malignancies, influencing cancer cell proliferation, survival, and death.
  • TRPM channels play roles in tumor progression via epithelial-mesenchymal transition (EMT), autophagy, and metabolic reprogramming.

Purpose of the Study:

  • To review the characteristics of TRPM channels.
  • To elucidate the connection between TRPM channels and key cancer features.
  • To discuss the therapeutic potential of TRPM modulators in oncology.

Main Methods:

  • Literature review and synthesis of current research on TRPM channels in cancer.
  • Analysis of TRPM channel involvement in cancer hallmarks like EMT, autophagy, and metabolism.
  • Examination of TRPM modulators in preclinical and clinical studies.

Main Results:

  • TRPM channels are implicated in fundamental cancer processes, including growth, survival, and metastasis.
  • Evidence supports TRPM channels as potential molecular targets for cancer therapy.
  • TRPM modulators are being investigated as novel anti-cancer agents.

Conclusions:

  • TRPM channels represent a significant area of research in oncology.
  • Modulating TRPM channel activity offers a potential innovative therapeutic strategy for cancer treatment.
  • Further investigation into TRPM channels and their modulators is warranted for clinical application in oncology.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.9K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K